Enlivex Therapeutics Statistics

Total Valuation

TLV:ENLV has a market cap or net worth of ILS 95.16 million. The enterprise value is 38.50 million.

Market Cap	95.16M
Enterprise Value	38.50M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	24.29M
Shares Outstanding	n/a
Shares Change (YoY)	+20.50%
Shares Change (QoQ)	+0.80%
Owned by Insiders (%)	4.52%
Owned by Institutions (%)	5.25%
Float	23.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.64
P/TBV Ratio	1.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.92
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.97

Financial Position

The company has a current ratio of 6.43, with a Debt / Equity ratio of 0.04.

Current Ratio	6.43
Quick Ratio	6.26
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -57.64% and return on invested capital (ROIC) is -40.13%.

Return on Equity (ROE)	-57.64%
Return on Assets (ROA)	-36.02%
Return on Invested Capital (ROIC)	-40.13%
Return on Capital Employed (ROCE)	-81.64%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	71
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.34% in the last 52 weeks. The beta is 1.48, so TLV:ENLV's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	-17.34%
50-Day Moving Average	342.49
200-Day Moving Average	374.73
Relative Strength Index (RSI)	53.18
Average Volume (20 Days)	179,182

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-48.41M
Pretax Income	-42.05M
Net Income	-42.05M
EBITDA	-47.44M
EBIT	-48.41M
Earnings Per Share (EPS)	-1.79

Full Income Statement

Balance Sheet

The company has 60.27 million in cash and 2.32 million in debt, giving a net cash position of 57.95 million.

Cash & Cash Equivalents	60.27M
Total Debt	2.32M
Net Cash	57.95M
Net Cash Per Share	n/a
Equity (Book Value)	57.88M
Book Value Per Share	2.38
Working Capital	54.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -39.32 million and capital expenditures -314,555, giving a free cash flow of -39.63 million.

Operating Cash Flow	-39.32M
Capital Expenditures	-314,555
Free Cash Flow	-39.63M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TLV:ENLV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.50%
Shareholder Yield	-20.50%
Earnings Yield	-44.19%
FCF Yield	-41.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1